GlassScriptPhysician profile
Robert Woods
NPI 1457465668
$27,338.23
in general payments reported to CMS, 2019-2025
31 companies · $1,908 in 2025
The $1,908 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,076 · 2020: $1,611 · 2021: $2,560 · 2022: $5,818 · 2023: $8,876 · 2024: $2,490 · 2025: $1,908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,241 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Education: $32.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,241.10 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Education | $32.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15,270.38 | 2019-2025 | Watchman Access System, Watchman Flx, Cds - Mct/Cem Monitoring |
| Actelion Pharmaceuticals US, INC. | $3,108.02 | 2019-2025 | Uptravi, Opsumit, Acclaim |
| Janssen Pharmaceuticals, INC | $1,402.73 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,382.84 | 2019-2024 | Jardiance |
| Medtronic, INC. | $1,067.52 | 2021-2025 | Micra, Aurora Ev-Icd Mri Surescan |
| Amgen INC. | $574.73 | 2021-2024 | Repatha |
| Merck Sharp & Dohme LLC | $572.47 | 2022-2025 | Winrevair, Verquvo |
| Esperion Therapeutics, INC. | $479.39 | 2021-2023 | Nexletol |
| Pfizer INC. | $460.66 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $408.37 | 2021-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $362.63 | 2019-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $351.80 | 2020-2024 | Farxiga, Andexxa |
| Novartis Pharmaceuticals Corporation | $349.14 | 2020-2024 | Leqvio |
| Edwards Lifesciences Corporation | $283.68 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $189.53 | 2019-2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $170.45 | 2020-2022 | |
| Irhythm Technologies, INC. | $154.15 | 2024 | Zio Xt Patch, Zio Monitor |
| Abbott Laboratories | $152.52 | 2021-2024 | Assurity |
| Corcept Therapeutics | $115.00 | 2025 | Korlym |
| Biotronik Nro, INC. | $93.06 | 2025 | Prospera |
| Biotronik INC. | $62.32 | 2022-2024 | Amvia Edge |
| Kiniksa Pharmaceuticals, LTD. | $58.71 | 2023 | Arcalyst |
| Novo Nordisk INC | $56.71 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Lexicon Pharmaceuticals, INC. | $47.66 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $38.69 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $28.00 | 2022 | |
| Daiichi Sankyo INC. | $26.77 | 2023 | Injectafer |
| Philips North America LLC | $24.71 | 2020 | |
| Scpharmaceuticals INC. | $20.24 | 2024 | |
| Baxter Healthcare | $13.43 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Elutia, INC. | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.